BioCentury
ARTICLE | Financial News

PharmAthene planning follow-on

October 29, 2010 12:55 AM UTC

PharmAthene Inc. (NYSE-A:PIP) said late Thursday that it is planning a follow-on underwritten by Roth Capital Partners. Further details were not disclosed. PharmAthene's SparVax recombinant protective...